Last reviewed · How we verify

NCT05507255

Effect of Aerobic Exercise on Diurnal Cortisol Pattern in Premenstrual Syndrome

Completed NA Last updated 27 June 2023
What this trial tests

NA trial testing Relaxation training in Premenstrual Syndrome in 28 participants. Completed in 1 June 2023.

Timeline
1 February 2023
Primary endpoint
1 June 2023
1 June 2023

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment28
Start date1 February 2023
Primary completion1 June 2023
Estimated completion1 June 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 23, female only, with Premenstrual Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study will be to investigate the effect of aerobic exercise on diurnal cortisol pattern in premenstrual syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Relaxation training

Trials testing the same drug.

Other recruiting trials for Premenstrual Syndrome

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05507255.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing